Cooper Companies Inc  

(Public, NYSE:COO)   Watch this stock  
Find more results for CAROL ROSENBERG�
162.87
+0.59 (0.36%)
Dec 19 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 161.07 - 163.41
52 week 116.95 - 171.54
Open 162.29
Vol / Avg. 758,969.00/753,688.00
Mkt cap 7.86B
P/E 29.61
Div/yield 0.03/0.04
EPS 5.50
Shares 48.00M
Beta 0.14
Inst. own 102%
Mar 16, 2015
The Cooper Companies, Inc. Annual Shareholder Meeting (Estimated) Add to calendar
Mar 4, 2015
Q1 2015 Cooper Companies Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 4, 2014
Q4 2014 Cooper Companies Inc Earnings Call - Webcast
Dec 4, 2014
Q4 2014 Cooper Companies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin 6.68% 15.82%
Operating margin 8.41% 17.84%
EBITD margin - 19.92%
Return on average assets 3.20% 7.16%
Return on average equity 4.72% 10.85%
Employees 8,000 -
CDP Score - -

Address

Suite 590, 6140 Stoneridge Mall Road
PLEASANTON, CA 94588
United States - Map
+1-925-4603600 (Phone)
+1-925-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Company�s brands include Biofinity, Avaira and MyDay and CooperSurgical Company�s brands include Advincula Arch, SeeClear and Mobius.

Officers and directors

A. Thomas Bender Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Weiss President, Chief Executive Officer, Non-Independent Director
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allan E. Rubenstein M.D. Independent Vice Chairman of the Board, Lead Director
Age: 65
Bio & Compensation  - Reuters
Gregory W. Matz Chief Financial Officer, Chief Risk Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Paul L. Remmell President and Chief Executive Officer of CooperSurgical Inc.
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel G. McBride Esq. Chief Operating Officer, Executive Vice President; President of CooperVision, Inc.
Age: 49
Bio & Compensation  - Reuters
Carol R. Kaufman Executive Vice President, Chief Administrative Officer, Secretary, Chief Governance Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tina Maloney Principal Accounting Officer, Corporate Controller
Age: 51
Bio & Compensation  - Reuters
Albert G. White III Vice President, Chief Strategy Officer
Age: 44
Bio & Compensation  - Reuters
Randal L. Golden Esq. General Counsel
Age: 52
Bio & Compensation  - Reuters